/Investor DB

Old College Capital — 2024 Investments

4 investments dated 2024 · listed companies and verified rows first · show all

Carcinotechcarcinotech.cominJan 2024

Carcinotech produces bioprinted tumor models combining patient-derived biological material with automated workflows to generate reproducible tumor tissue systems for drug discovery and testing.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesEdinburgh, GB

Lorna(Chief Scientific Officer)

Co-investorsAlba EquityTRICAPITALBritish Business BankEos AdvisoryGabriel Investment SyndicateInvesting Women Angels+4 more

Carcinotechcarcinotech.co.ukinFeb 2024

Carcinotech develops tumor models and assay solutions to improve preclinical drug development for cancer therapies.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesScotland, GB

Albert Nicholl(Director)Ishani Malhotra(Executive Officer, Director)Ian David Waddell(Director)Lorna(Chief Scientific Officer)Susanne

Co-investorsEos AdvisoryAlba EquityGabriel Investment SyndicateInvesting Women AngelsInvestment Fund for ScotlandMaven Capital Partners+2 more

Cloud Concinnitytheconcinnitycompany.cominDec 2024

The Concinnity Company provides a cloud-based process management and automation platform designed to reduce delays and improve efficiency in clinical trials.

Cloud ComputingDigital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSNashville, US

Heidi Solomon Allen(Secretary)inMichael Alan Lalor(Chief Financial Officer)Nancy Falls(Chief Executive Officer)inMichelle Flynn(Director)Philip Hertik(Director)Edward Townes Duncan(Director)

Co-investorsEos AdvisoryMaven Capital PartnersScottish Enterprise

Wobble Genomicswobblegenomics.cominMar 2024

Wobble Genomics operates an RNA sequencing platform that captures full-length RNA transcripts to identify long RNA biomarkers and novel isoforms for precision medicine.

BiotechDeep TechDigital HealthHealthtechMedical DevicesEdinburgh

Richard Izen Kuo(Executive Officer, Director)Joanna Smart(Director)Lee James Lindley(Director)John Harris Leamon(Director)Trevor John Nicholls(Director)John Robert Fraser Duncan(Director)

Co-investorsEos AdvisoryIQ CapitalMercia Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.